Journal
REVISTA ESPANOLA DE QUIMIOTERAPIA
Volume 35, Issue -, Pages 34-36Publisher
SOCIEDAD ESPANOLA QUIMIOTERAPIA
DOI: 10.37201/req/s03.08.2022
Keywords
HIV; antiretroviral therapy; dolutegravir; bictegravir.
Categories
Ask authors/readers for more resources
The treatment of HIV infection is crucial for both individual health and the prevention of transmission. It should be initiated as early as possible, ideally on the same day of diagnosis or within the first week. Effective and convenient antiretroviral regimens incorporating second-generation integrase inhibitors are currently available.
The treatment of HIV infection has become a cornerstone for the global control of the pandemic due to its benefits on individual health and for preventing the transmission of HIV. It should be started in all people with HIV infection and as quickly as possible. Ideally, it should be started on the same day of diagnosis or, failing that, within the first 7 days. Antiretroviral regimens with excellent efficacy, no significant toxicity, and convenient administration are currently available for initiation of antiretroviral treatment. They can incorporate two or three drugs and are always based on a second-generation integrase inhibitor.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available